SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ValiRx Plc Announces Promising In Vivo Data for Therapeutic Cancer Compound VAL 101, Based on its Gene Silencing GeneICET Technology Platform